ETIHX | JFNIX | ETIHX / JFNIX | |
Total Expense Ratio | 1.32 | 0.77 | 171% |
Annual Report Gross Expense Ratio | 1.32 | 0.77 | 171% |
Fund Existence | 13 years | 16 years | - |
Gain YTD | 23.482 | 3.176 | 739% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 2500 | 4,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.33B | 4.49B | 30% |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | 13.99 | -12.39 | -113% |
Returns for 3 years | 39.55 | 21.30 | 186% |
Returns for 5 years | -5.17 | 8.34 | -62% |
Returns for 10 years | 102.74 | 39.28 | 262% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RLUEX | 12.57 | N/A | N/A |
Lazard US Equity Concentrated R6 | |||
FBDIX | 143.61 | N/A | N/A |
Franklin Biotechnology Discovery A | |||
CFSIX | 21.84 | N/A | N/A |
Touchstone Sands Capital Select Growth Y | |||
TIBRX | 31.71 | N/A | N/A |
Thornburg Investment Income Builder R3 | |||
BIRDX | 8.53 | N/A | N/A |
iShares Developed Real Estate Idx Instl |